Everything you need to know about The Handmaid’s Tale Season 6, including its Hulu release date, cast, plot, and more.
A groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to Donald Trump's ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Charles Schwab Corp. (SCHW), ...
14h
Hosted on MSNGilead’s lenacapavir applications for HIV gain EMA validationGilead Sciences has announced the European Medicines Agency’s (EMA) validation for a parallel accelerated review of ...
Three bovine veterinarians had undetected H5N1 avian influenza infections despite no apparent contact with infected cows, ...
Wrestling sectionals were held over the weekend and Marion-area competitors earned berths into the upcoming district ...
Salesforce is expected to report fourth-quarter results after the market closes Wednesday, with analysts largely bullish on the cloud-based software company's stock, anticipating AI-driven gains.
The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors ...
The discussion ended with a bold call to action for businesses, healthcare providers, and policymakers: health equity must be a priority—not just ethically, but economically. As Burgess put it: “This ...
The Pirates jumped out to a 23-6 lead after the opening quarter and outscored their opponents 17-2 in the second quarter and 17-3 in the third to open up a commanding lead in the win. Warren Garrison ...
The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results